GSK
Gsk Plc-spon Adr. Earnings
$38.06
Earnings Summary
Revenue | $7516Mn |
Net Profits | $1624Mn |
Net Profit Margins | 21.61% |
PE Ratio | 18.66 |
Gsk Plc-spon Adr.’s revenue jumped 2.08% since last year same period to $7516Mn in the Q1 2025. On a quarterly growth basis, Gsk Plc-spon Adr. has generated -7.4% fall in its revenue since last 3-months.
Gsk Plc-spon Adr.’s net profit jumped 55.26% since last year same period to $1624Mn in the Q1 2025. On a quarterly growth basis, Gsk Plc-spon Adr. has generated 292.27% jump in its net profits since last 3-months.
Gsk Plc-spon Adr.’s net profit margin jumped 52.1% since last year same period to 21.61% in the Q1 2025. On a quarterly growth basis, Gsk Plc-spon Adr. has generated 323.64% jump in its net profit margins since last 3-months.
Gsk Plc-spon Adr.’s price-to-earnings ratio after this Q1 2025 earnings stands at 18.66.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 1.04 |
EPS Estimate Current Year | 1.04 |
Gsk Plc-spon Adr.’s earning per share (EPS) estimates for the current quarter stand at 1.04 - a 113.45% jump from last quarter’s estimates.
Gsk Plc-spon Adr.’s earning per share (EPS) estimates for the current year stand at 1.04.
Key Ratios
Earning Per Share (EPS) | 1.2 |
Return on Assets (ROA) | 0.07 |
Return on Equity (ROE) | 0.27 |
Dividend Per Share (DPS) | 0.4 |
Gsk Plc-spon Adr.’s earning per share (EPS) jumped 10.42% since last year same period to 1.2 in the Q1 2025. This indicates that the Gsk Plc-spon Adr. has generated 10.42% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Gsk Plc-spon Adr.’s return on assets (ROA) stands at 0.07.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Gsk Plc-spon Adr.’s return on equity (ROE) stands at 0.27.
Gsk Plc-spon Adr. declared 0.4 dividend per share during the earnings announcement for Q1 2025.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-04-30 | 1.04 | 1.2 | 15.64% |
